EUROFINS SCIENT - 20 Year Stock Price History | ERFSF
Historical daily share price chart and data for EUROFINS SCIENT since 2005 adjusted for splits and dividends. The latest closing stock price for EUROFINS SCIENT as of July 02, 2025 is 71.01.
- The all-time high EUROFINS SCIENT stock closing price was 141.87 on September 03, 2021.
- The EUROFINS SCIENT 52-week high stock price is 73.79, which is 3.9% above the current share price.
- The EUROFINS SCIENT 52-week low stock price is 46.36, which is 34.7% below the current share price.
- The average EUROFINS SCIENT stock price for the last 52 weeks is 56.36.
| EUROFINS SCIENT Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 57.8961 | 51.0283 | 73.6100 | 45.8384 | 71.0100 | 36.94% |
| 2024 | 56.5587 | 63.5762 | 65.4869 | 45.8286 | 51.8547 | -17.54% |
| 2023 | 61.6915 | 67.1704 | 72.4920 | 46.0960 | 62.8858 | -9.64% |
| 2022 | 78.8743 | 114.6740 | 114.6740 | 52.8903 | 69.5932 | -42.26% |
| 2021 | 107.0636 | 81.9425 | 141.8650 | 81.9425 | 120.5240 | 55.21% |
| 2020 | 63.2186 | 53.2376 | 85.5425 | 40.5236 | 77.6545 | 45.56% |
| 2019 | 42.4936 | 34.6587 | 54.0566 | 31.2527 | 53.3498 | 51.54% |
| 2018 | 47.9414 | 58.6595 | 61.6670 | 33.1774 | 35.2060 | -37.62% |
| 2017 | 49.9453 | 40.1045 | 60.4491 | 38.6718 | 56.4342 | 43.50% |
| 2016 | 35.9680 | 32.3056 | 43.1839 | 28.7408 | 39.3283 | 20.21% |
| 2015 | 28.3267 | 23.6827 | 35.3064 | 22.8789 | 32.7164 | 39.36% |
| 2014 | 25.3683 | 25.0390 | 30.0788 | 20.2814 | 23.4760 | -6.46% |
| 2013 | 22.0539 | 17.7129 | 25.0975 | 17.7129 | 25.0975 | 70.55% |
| 2012 | 12.1969 | 6.5370 | 14.8289 | 6.5370 | 14.7153 | 103.40% |
| 2011 | 7.6430 | 7.4630 | 8.2312 | 7.2348 | 7.2348 | 66.13% |
| 2010 | 3.8085 | 3.8197 | 4.3549 | 3.2820 | 4.3549 | 8.86% |
| 2009 | 4.2406 | 4.2050 | 4.8607 | 3.7724 | 4.0004 | -3.88% |
| 2008 | 6.8350 | 9.2502 | 9.2502 | 3.4541 | 4.1620 | -46.89% |
| 2007 | 7.5336 | 6.9976 | 8.1110 | 6.9976 | 7.8370 | 32.90% |
| 2006 | 5.2303 | 4.3681 | 5.8970 | 4.3681 | 5.8970 | 60.13% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.673B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.424B | 27.28 |
| CVS Health (CVS) | United States | $85.300B | 10.60 |
| Elevance Health (ELV) | United States | $78.589B | 10.14 |
| Cencora (COR) | United States | $57.416B | 19.98 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.088B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.920B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| Solventum (SOLV) | United States | $13.582B | 14.38 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.122B | 11.27 |
| Revvity (RVTY) | United States | $11.941B | 20.55 |
| Viatris (VTRS) | United States | $10.939B | 3.76 |
| Avantor (AVTR) | United States | $9.458B | 13.74 |
| Medpace Holdings (MEDP) | United States | $9.241B | 24.54 |
| HealthEquity (HQY) | United States | $8.834B | 38.70 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.717B | 15.12 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.752B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.910B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.889B | 35.68 |
| Sotera Health (SHC) | United States | $3.334B | 18.94 |
| Surgery Partners (SGRY) | United States | $2.839B | 36.92 |
| Alignment Healthcare (ALHC) | United States | $2.685B | 0.00 |
| Concentras Parent (CON) | United States | $2.635B | 15.23 |
| GeneDx Holdings (WGS) | United States | $2.614B | 100.67 |
| Organon (OGN) | United States | $2.589B | 2.75 |
| PACS (PACS) | United States | $2.003B | 0.00 |
| Ardent Health (ARDT) | United States | $1.915B | 8.16 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.812B | 13.76 |
| GoodRx Holdings (GDRX) | United States | $1.682B | 33.64 |
| Teladoc Health (TDOC) | United States | $1.454B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.259B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.071B | 16.73 |
| Agilon Health (AGL) | United States | $1.006B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.86 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| Embecta (EMBC) | United States | $0.603B | 4.06 |
| InnovAge Holding (INNV) | United States | $0.602B | 0.00 |
| LifeMD (LFMD) | United States | $0.568B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| Omada Health (OMDA) | $0.480B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 31.88 |
| So-Young (SY) | China | $0.330B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.328B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.305B | 0.00 |
| Beauty Health (SKIN) | United States | $0.287B | 0.00 |
| Oncology Institute (TOI) | United States | $0.225B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 26.33 |
| Pheton Holdings (PTHL) | China | $0.126B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.094B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |